Genetic studies of MIS signalling in sexual development

Novartis Foundation Symposium

Volumn 244, Issue , 2002, Pages 157-168

  Jamin, Soazik P ^a   Arango, Nelson A ^a   Mishina, Yuji ^a   Behringer, Richard R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GROWTH INHIBITOR; MULLERIAN INHIBITING HORMONE; MULLERIAN INHIBITING SUBSTANCE RECEPTOR; MULLERIAN-INHIBITING HORMONE; MULLERIAN-INHIBITING SUBSTANCE RECEPTOR; RECEPTOR; TESTIS PEPTIDE HORMONE;

ANIMAL; FEMALE; GENETICS; MALE; MOUSE; PHYSIOLOGY; REVIEW; SEX DIFFERENTIATION; SIGNAL TRANSDUCTION;

ANIMALS; FEMALE; GLYCOPROTEINS; GROWTH INHIBITORS; MALE; MICE; RECEPTORS, PEPTIDE; SEX DIFFERENTIATION; SIGNAL TRANSDUCTION; TESTICULAR HORMONES;

EID: 0040074447     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (27)

1. Arango NA, Lovell-Badge R, Behringer RR 1999 Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell 99:409-419
2. Baarends WM, van Helmond MJL, Post M et al 1994 A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Müllerian duct. Development 120:189-197
3. Behringer RR, Cate RL, Froelick GJ, Palmiter RD, Brinster RL 1990 Abnormal sexual development in transgenic mice chronically expressing Müllerian inhibiting substance. Nature 345:167-170
4. Behringer RR, Finegold MJ, Cate RL 1994 Müllerian-inhibiting substance function during mammalian sexual development. Cell 79:415-425
5. Belville C, Josso N, Picard J-Y 1999 Persistence of Müllerian derivatives in males. Am J Med Genet 89:218-223
6. Clarke TR, Hoshiya Y, Yi SE, Liu X, Lyons KM, Donahoe PK 2001 Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Mol Endocrinol 15:946-959
7. di Clemente N, Wilson C, Faure E et al 1994 Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Mol Endocrinol 8:1006-1020
8. Gouédard L, Chen YG, Thevenet L et al 2000 Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Mullerian hormone and its type II receptor. J Biol Chem 275:27973-27978
9. Gu Z, Nomura M, Simpson BB et al 1998 The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse. Genes Dev 12:844-857
10. Gu Z, Reynolds EM, Song J et al 1999 The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo. Development 126:2551-2561
11. Imbeaud S, Faure E, Lamarre I et al 1995 Insensitivity to anti-Müllerian hormone due to a mutation in the human anti-Müllerian hormone receptor. Nat Genet 11:382-388
12. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR 2002 BMPR-IA is a type I receptor that is required for male sexual differentiation in mammals. Submitted
13. Josso N, Cate RL, Picard JY et al 1993 Anti-Müllerian hormone: the Jost factor. Recent Prog Horm Res 48:1-59
14. Lee MM, Seah CC, Masiakos PT et al 1999 Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells. Endocrinology 140:2819-2827
15. Massagué J, Blain SW, Lo RS 2000 TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103:295-309
16. Mishina Y, Suzuki A, Ueno N, Behringer RR 1995 Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 15:3027-3037
17. Mishina Y, Rey R, Finegold MJ et al 1996 Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 10:2577-2587
18. Mishina Y, Tizard R, Deng JM et al 1997 Sequence, genomic organization, and chromosomal location of the mouse Mullerian-inhibiting substance type II receptor gene. Biochem Biophys Res Commun 237:741-746
19. Mishina Y, Whitworth DJ, Racine C, Behringer RR 1999a High specificity of Mullerian-inhibiting substance signaling in vivo. Endocrinology 140:2084-2088
20. Mishina Y, Crombie R, Bradley A, Behringer RR 1999b Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis. Dev Biol 213:314-326
21. Nagy A 2000 Cre recombinase: the universal reagent for genome tailoring. Genesis 26:116-117
22. Oh SP, Seki T, Goss KA et al 2000 Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci USA 97:2626-2631
23. Racine C, Rey R, Forest MG et al 1998 Receptors for anti-Müllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation. Proc Natl Acad Sci USA 95:594-599
24. Soriano P 1999 Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21:70-71
25. Teixeira J, He WW, Shah PC et al 1996 Developmental expression of a candidate Mullerian inhibiting substance type II receptor. Endocrinology 137:160-165
26. Visser JA, Olaso R, Verhoef-Post M, Kramer P, Themmen AP, Ingraham HA 2001 The serine/ threonine transmembrane receptor ALK2 mediates Mullerian inhibiting substance signaling. Mol Endocrinol 15:936-945
27. Yi SE, Daluiski A, Pederson R, Rosen V, Lyons KM 2000 The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development 127:621-630